Team:UB Indonesia

From 2014.igem.org

(Difference between revisions)
Line 85: Line 85:
</div><!-- /slide1 -->
</div><!-- /slide1 -->
-
<!-- === Slide 2 === -->
+
<!-- === Slide 2 / Project=== -->
<div class="slide story" id="slide-2" data-slide="2">
<div class="slide story" id="slide-2" data-slide="2">
<div class="container">
<div class="container">
Line 99: Line 99:
<div class="row content-row">
<div class="row content-row">
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#background" class="fancybox"><p><i class="icon icon-eye-open"></i></p></a>
+
<a href="#background" class="fancybox"><p><i class="icon icon-dekstop"></i></p></a>
<div id="background" style="display:none;width:700px;">
<div id="background" style="display:none;width:700px;">
<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;According to Bosch FX (2003), cervical cancer is one of the most common cancers in women worldwide, with an estimated global incidence of 470,000 new cases and approximately 233,000 deaths per year. Then, we try to make an idea to build a new prototype for early detection to cervical cancer, especially caused by HPV 18 and HPV 16. From the previous results of the two teams, Calgary Team 2013 and Freiburg Team 2012, we build a new prototype with some combination from those teams. We learn about the prototype sensor from Calgary Team 2012 that consist of detector, linker, and reporter that combined into one small test pack. Then, to make the detector, we learn from Freiburg Team 2012 to constructing a new specific TALEs that can bind to our target sequences and we called it TALE 1 and TALE 2. <br><br>
<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;According to Bosch FX (2003), cervical cancer is one of the most common cancers in women worldwide, with an estimated global incidence of 470,000 new cases and approximately 233,000 deaths per year. Then, we try to make an idea to build a new prototype for early detection to cervical cancer, especially caused by HPV 18 and HPV 16. From the previous results of the two teams, Calgary Team 2013 and Freiburg Team 2012, we build a new prototype with some combination from those teams. We learn about the prototype sensor from Calgary Team 2012 that consist of detector, linker, and reporter that combined into one small test pack. Then, to make the detector, we learn from Freiburg Team 2012 to constructing a new specific TALEs that can bind to our target sequences and we called it TALE 1 and TALE 2. <br><br>
Line 110: Line 110:
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#overview" class="fancybox"><p><i class="icon icon-laptop"></i></p></a>
+
<a href="#overview" class="fancybox"><p><i class="icon icon-eye-open"></i></p></a>
                                         <div id="overview" style="display:none;width:700px;">
                                         <div id="overview" style="display:none;width:700px;">
<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro or in silico, EGCG is able to inhibit the proliferation of cancer cells because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.  We design siRNA sequence from LAR gene (to inhibit non-EGCG compound) using bioinformatics tool and use P97 promoter to initiate expression in mammalian cell (using HeLa cell). That part will be insert into the psB1C3 linear backbone. To checking performance of this part, we insert sequence target of siRNA into the plasmid Bba_E0240 and get the promoter CMV from Bba_K747096 part. We also prepare for positive control and negative control for this experiment. Positive control part containing siRNA for GFP, insert into Bba_K747096 part that contain CMV promoter, and negative control containing CMV promoter and insert to the Bba_E0240 part containing GFP. Each part will be growth in HeLa cell culture and observed the succeding by fluorescent microscope.</p>
<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tea plant (Camelia sinensis) has catechin compounds that contains antioxidants.  Catechin family that most effective used as antioxidant is Epigallocathecin gallate (EGCG).  Based on research in vitro or in silico, EGCG is able to inhibit the proliferation of cancer cells because stop over-expression between L1 HPV 16- EGFR (Epithel Growth Factor Receptor) bond but there are few of EGCG content in tea plant. Based on these problems, we would to over- expression EGCG by knockdown non-compound EGCG gene, so hopefully the content of EGCG on tea are more prominent.  We design siRNA sequence from LAR gene (to inhibit non-EGCG compound) using bioinformatics tool and use P97 promoter to initiate expression in mammalian cell (using HeLa cell). That part will be insert into the psB1C3 linear backbone. To checking performance of this part, we insert sequence target of siRNA into the plasmid Bba_E0240 and get the promoter CMV from Bba_K747096 part. We also prepare for positive control and negative control for this experiment. Positive control part containing siRNA for GFP, insert into Bba_K747096 part that contain CMV promoter, and negative control containing CMV promoter and insert to the Bba_E0240 part containing GFP. Each part will be growth in HeLa cell culture and observed the succeding by fluorescent microscope.</p>
Line 118: Line 118:
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-tablet"></i></p></a>
+
<a href="#"><p><i class="icon icon-shield"></i></p></a>
<h2 class="font-thin"><font color="#fff">Preventing</font></h2>
<h2 class="font-thin"><font color="#fff">Preventing</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-pencil"></i></p></a>
+
<a href="#"><p><i class="icon icon-stethoscope"></i></p></a>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-pencil"></i></p></a>
+
<a href="#"><p><i class="icon icon-medkit"></i></p></a>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-pencil"></i></p></a>
+
<a href="#"><p><i class="icon icon-trophy"></i></p></a>
<h2 class="font-thin"><font color="#fff">Achievement</font></h2>
<h2 class="font-thin"><font color="#fff">Achievement</font></h2>
<font color="#fff"><h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<font color="#fff"><h4 class="font-thin"><font color="#fff">Detail.</font></h4>
Line 141: Line 141:
</div><!-- /slide2 -->
</div><!-- /slide2 -->
-
<!-- === SLide 3 - Portfolio -->
+
<!-- === SLide 3 - Galery -->
<div class="slide story" id="slide-3" data-slide="3">
<div class="slide story" id="slide-3" data-slide="3">
<div class="row">
<div class="row">
Line 159: Line 159:
</div><!-- /slide3 -->
</div><!-- /slide3 -->
-
<!-- === Slide 4 - Process === -->
+
<!-- === Slide 4 - Modeling === -->
<div class="slide story" id="slide-4" data-slide="4">
<div class="slide story" id="slide-4" data-slide="4">
<div class="container">
<div class="container">
<div class="row title-row">
<div class="row title-row">
-
<div class="col-12 font-semibold">Modeling</div>
+
<div class="col-12 font-semibold">MODELING</div>
</div><!-- /row -->
</div><!-- /row -->
<div class="row line-row">
<div class="row line-row">
Line 175: Line 175:
<div class="row content-row">
<div class="row content-row">
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-bolt"></i></p></a>
+
<a href="#"><p><i class="icon icon-shield"></i></p></a>
<h2 class="font-thin"><font color="#fff">Preventing</font></h2>
<h2 class="font-thin"><font color="#fff">Preventing</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cog"></i></p></a>
+
<a href="#"><p><i class="icon icon-stethoscope"></i></p></a>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h2 class="font-thin"><font color="#fff">Screening</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cloud"></i></p></a>
+
<a href="#"><p><i class="icon icon-medkit"></i></p></a>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h2 class="font-thin"><font color="#fff">Therapy</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
Line 194: Line 194:
</div><!-- /slide4 -->
</div><!-- /slide4 -->
-
<!-- === Slide 5 === -->
+
<!-- === Slide 5 /Notebook === -->
<div class="slide story" id="slide-5" data-slide="5">
<div class="slide story" id="slide-5" data-slide="5">
<div class="container">
<div class="container">
Line 210: Line 210:
<div class="row content-row">
<div class="row content-row">
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-bolt"></i></p></a>
+
<a href="#"><p><i class="icon icon-calendar"></i></p></a>
<h2 class="font-thin"><font color="#fff">Timeline</font></h2>
<h2 class="font-thin"><font color="#fff">Timeline</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cog"></i></p></a>
+
<a href="#"><p><i class="icon icon-book"></i></p></a>
<h2 class="font-thin"><font color="#fff">Lab Journal</font></h2>
<h2 class="font-thin"><font color="#fff">Lab Journal</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cloud"></i></p></a>
+
<a href="#"><p><i class="icon icon-flask"></i></p></a>
<h2 class="font-thin"><font color="#fff">Method</font></h2>
<h2 class="font-thin"><font color="#fff">Method</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
Line 229: Line 229:
</div><!-- /slide5 -->
</div><!-- /slide5 -->
-
<!-- === Slide 6 / Contact === -->
+
<!-- === Slide 6 / Human Practice === -->
<div class="slide story" id="slide-6" data-slide="6">
<div class="slide story" id="slide-6" data-slide="6">
<div class="container">
<div class="container">
Line 245: Line 245:
<div class="row content-row">
<div class="row content-row">
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-bolt"></i></p></a>
+
<a href="#"><p><i class="icon icon-chain"></i></p></a>
<h2 class="font-thin"><font color="#fff">Collaborations</font></h2>
<h2 class="font-thin"><font color="#fff">Collaborations</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cog"></i></p></a>
+
<a href="#"><p><i class="icon icon-pencil"></i></p></a>
<h2 class="font-thin"><font color="#fff">Education</font></h2>
<h2 class="font-thin"><font color="#fff">Education</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cloud"></i></p></a>
+
<a href="#"><p><i class="icon icon-group"></i></p></a>
<h2 class="font-thin"><font color="#fff">Society</font></h2>
<h2 class="font-thin"><font color="#fff">Society</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
Line 264: Line 264:
</div><!-- /Slide 6 -->
</div><!-- /Slide 6 -->
-
<!-- === Slide 7 - Process === -->
+
<!-- === Slide 7 - Safety === -->
<div class="slide story" id="slide-7" data-slide="7">
<div class="slide story" id="slide-7" data-slide="7">
<div class="container">
<div class="container">
Line 280: Line 280:
<div class="row content-row">
<div class="row content-row">
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-bolt"></i></p></a>
+
<a href="#"><p><i class="icon icon-chain"></i></p></a>
<h2 class="font-thin"><font color="#fff">Collaborations</font></h2>
<h2 class="font-thin"><font color="#fff">Collaborations</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cog"></i></p></a>
+
<a href="#"><p><i class="icon icon-pencil"></i></p></a>
<h2 class="font-thin"><font color="#fff">Education</font></h2>
<h2 class="font-thin"><font color="#fff">Education</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-4 col-sm-6">
<div class="col-12 col-lg-4 col-sm-6">
-
<a href="#"><p><i class="icon icon-cloud"></i></p></a>
+
<a href="#"><p><i class="icon icon-group"></i></p></a>
<h2 class="font-thin"><font color="#fff">Society</font></h2>
<h2 class="font-thin"><font color="#fff">Society</font></h2>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
<h4 class="font-thin"><font color="#fff">Detail.</font></h4>
Line 299: Line 299:
</div><!-- /slide7 -->
</div><!-- /slide7 -->
-
<!-- === SLide 8 - Portfolio -->
+
<!-- === SLide 8 - About Us -->
<div class="slide story" id="slide-8" data-slide="8">
<div class="slide story" id="slide-8" data-slide="8">
<div class="row title-row">
<div class="row title-row">
Line 314: Line 314:
<div class="row content-row">
<div class="row content-row">
<div class="col-12 col-lg-6 col-sm-6">
<div class="col-12 col-lg-6 col-sm-6">
-
<a href="#"><p><i class="icon icon-bolt"></i></p></a>
+
<a href="#"><p><i class="icon icon-user"></i></p></a>
<h2 class="font-thin"><font color="#fff">Members</font></h2>
<h2 class="font-thin"><font color="#fff">Members</font></h2>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-6 col-sm-6">
<div class="col-12 col-lg-6 col-sm-6">
-
<a href="#"><p><i class="icon icon-cog"></i></p></a>
+
<a href="#"><p><i class="icon icon-star"></i></p></a>
<h2 class="font-thin"><font color="#fff">Sponsors</font></h2>
<h2 class="font-thin"><font color="#fff">Sponsors</font></h2>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-6 col-sm-6">
<div class="col-12 col-lg-6 col-sm-6">
-
<a href="#"><p><i class="icon icon-cloud"></i></p></a>
+
<a href="#"><p><i class="icon icon-camera-retro"></i></p></a>
<h2 class="font-thin"><font color="#fff">Gallery</font></h2>
<h2 class="font-thin"><font color="#fff">Gallery</font></h2>
</div><!-- /col12 -->
</div><!-- /col12 -->
<div class="col-12 col-lg-6 col-sm-6">
<div class="col-12 col-lg-6 col-sm-6">
-
<a href="#"><p><i class="icon icon-cloud"></i></p></a>
+
<a href="#"><p><i class="icon icon-globe"></i></p></a>
<h2 class="font-thin"><font color="#fff">Attributions</font></h2>
<h2 class="font-thin"><font color="#fff">Attributions</font></h2>
</div><!-- /col12 -->
</div><!-- /col12 -->

Revision as of 05:16, 15 October 2014

iGEM2014 | UB INDONESIA

BRAWIJAYA UNIVERSITY , INDONESIA

This is team wiki to share our iGEM experience



iGEM UB
BRAWIJAYA UNIVERSITY
iGEM2014
PROJECT
 
Abstract ...

Background

Detail.

Overview

Detail.

Preventing

Detail.

Screening

Detail.

Therapy

Detail.

Achievement

Detail.

MODELING
 
Teks description

Preventing

Detail.

Screening

Detail.

Therapy

Detail.

NOTEBOOK
 
Description

Timeline

Detail.

Lab Journal

Detail.

Method

Detail.

HUMAN PRACTICE
 
Description

Collaborations

Detail.

Education

Detail.

Society

Detail.

SAFETY
 
Description

Collaborations

Detail.

Education

Detail.

Society

Detail.

ABOUT US
 
Description

Members

Sponsors

Gallery

Attributions

Leave us a message
 
You can find us literally anywhere,

just push a button and we’re there

in/igemub

igemub@gmail.com

Malang, Indonesia
zip code 65145

facebook/igembrawijaya

@igem_ub